BioSpace News Archive

The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Conference Call and Webcast to Follow at 5:00 p.m. EDT / 2:00 p.m. PDT

Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

On that day, the Company will hold a teleconference call and live webcast at 5:30 p.m. ET to discuss the results

The nation’s largest independent provider of specialty pharmacy services sells certain assets to Diligent Health Solutions, LLC

New translational data will be presented for BT1718, the Company’s lead Bicycle® Toxin Conjugate (BTC) product candidate, which define enrollment criteria for identifying expansion cohorts in the Phase IIa part of the ongoing Phase I/IIa trial with BT1718.

Avidity Science is pleased to announce it has completed its acquisition of Edstrom Japan Ltd.

Third Quarter 2019 earnings conference call on Wednesday, October 23rd at 1:00 p.m. Eastern Time.

Natera, Inc., a global leader in cell-free DNA testing, announced the pricing of its underwritten public offering of 5,714,286 shares of its common stock at a price to the public of $35.00 per share.

Compulink Healthcare Solutions, the creator of Advantage SMART Practice®, an all-in-one EHR and practice management solution powered by artificial intelligence (AI), will showcase its Orthopaedic Advantage™ suite of Ortho-specific solutions at the American Shoulder and Elbow Surgeons annual meeting from October 16-19, 2019 in New York, NY.